Lomeguatrib was recently reported to be effective as a radiosensitizer in GBM cell lines carrying unmethylated MGMT promoters30, but robust studies to define the role of MGMT itself or MGMT inhibitors on radioresponse had not been performed. This evidence concerns the gene MGMT and glioblastoma.